Organon Pharma Indonesia Tbk PT
IDX:SCPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Organon Pharma Indonesia Tbk PT
Other
Organon Pharma Indonesia Tbk PT
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Organon Pharma Indonesia Tbk PT
IDX:SCPI
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other
-Rp131.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-7%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other
-Rp43.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other
-Rp44.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Organon Pharma Indonesia Tbk PT
Glance View
PT Organon Pharma Indonesia Tbk engages in the development, manufacture, and distribution of pharmaceutical products. The company is headquartered in Jakarta Pusat, Dki Jakarta. The firm is engaged in the processing, packaging and development of pharmaceutical products for human and animal consumption, toiletries, cosmetics, household and related products. The firm is also engaged in importing of raw materials, finished goods and providing business and management consultancy services. The Company’s segments include Pharmaceutical Manufacturing and commercial. For women's health, the Company develops product specifically for women, including contraception, fertility, pregnancy management, perinatal diseases and other diseases. The Company’s subsidiaries include Organon LLC, PT Merck Sharp & Dohme Indonesia, Merck Sharp & Dohme Corp and Merck Sharp & Dohme Asia.
